Judd Apatow Usa county Norman Art Instagram In the News Health love Actor Man Judd Apatow Usa county Norman

Pee-wee Herman actor Paul Reubens dies after private health battle

Reading now: 968
www.ok.co.uk

Follow OK! on Threads here: https://www.threads.net/@ok_mag Paul Reubens, who is best known for playing Pee-wee Herman has died at the age of 70.The actor died on Sunday night, 30 July, after a battle with cancer.

A statement posted to Instagram says: "Please accept my apology for not going public with what I’ve been facing the last six years.

I have always felt a huge amount of love and respect from my friends, fans and supporters. I have loved you all so much and enjoyed making art for you." In the caption, Reubens’ estate wrote: "Last night we said farewell to Paul Reubens, an iconic American actor, comedian, writer and producer whose beloved character Pee-wee Herman delighted generations of children and adults with his positivity, whimsy and belief in the importance of kindness." They continued: "Paul bravely and privately fought cancer for years with his trademark tenacity and wit.

A gifted and prolific talent, he will forever live in the comedy pantheon and in our hearts as a treasured friend and man of remarkable character and generosity of spirit.Tributes have been flooding on social media for the actor.

Read more on ok.co.uk
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

COVID-19: the green book, chapter 14a - gov.uk
gov.uk
36%
881
COVID-19: the green book, chapter 14a
PDF, 746 KB, 57 pagesThis file may not be suitable for users of assistive technology.This chapter includes information on:Updated mention of a table.Updated to include JCVI advice on vaccination for children aged 6 months to 4 years in a clinical risk group.Updated storage information for VidPrevtyn.Updated to include shortened background, separation between the historical pandemic response and the ongoing programme, spring booster campaign, explanation of the end of universal primary and booster offers, and describing the move to only offer vaccine during seasonal campaigns.Updated to include approval of Pfizer bivalent vaccine and further clarification around vaccination of under 12 year olds.Updated to include information on the autumn programme and variant vaccines, and further clarification of information on revaccination and capillary leak syndrome.Updated to include: approval of Novavax, clarification around deferral after COVID-19 infection, one-off programme for 5 to 11 year olds who are not in clinical risk groups, advice on use of the paediatric formulation in those aged 12 years, spring booster recommendations (including flexibility around timing) and expectations for an autumn booster, clarification of the management of individuals with a history of allergic reactions, updated advice on management of people who have ITP following vaccination.Updated background to include latest data on vaccine effectiveness and booster safety; clarified and corrected chronology of booster advice.
DMCA